Skip to main content
Almirall S.A. logo

Almirall S.A. — Investor Relations & Filings

Ticker · ALM ISIN · ES0157097017 LEI · 95980020140005007996 MC Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2020-06-10 AGM Information
Country ES Spain
Listing MC ALM

About Almirall S.A.

http://www.almirall.com

Almirall S.A. is a global biopharmaceutical company specializing in medical dermatology. The company focuses on the research, development, manufacturing, and commercialization of proprietary medicines to address significant unmet needs in skin health. Leveraging scientific innovation, Almirall provides medical solutions designed to improve the well-being and quality of life for patients. Its operations encompass in-house research and development, strategic partnerships, and in-licensing to expand its portfolio of dermatological treatments.

Recent filings

Filing Released Lang Actions
Convocatoria Junta General Ordinaria para su celebración por medios exclusivamente telemáticos
AGM Information Classification · 99% confidence The document is an official announcement from Almirall, S.A. detailing the convocation of its shareholders to an Annual General Meeting (Junta General Ordinaria de Accionistas) scheduled for July 24, 2020. The text explicitly lists the 'Orden del día' (Agenda), which includes items typical of an AGM, such as the approval of 2019 annual accounts, dividend distribution, capital increase proposals, board member re-elections/appointments, and statutory modifications. The document also details the procedures for remote attendance and voting due to the circumstances (COVID-19). This content directly corresponds to the purpose of an Annual General Meeting (AGM) announcement and related materials. Although the agenda items touch upon remuneration (Item 7, related to DEF 14A) and capital changes (Item 6, related to CAP/SHA), the primary function of this filing is the formal notice and agenda for the shareholder meeting itself. Therefore, the most appropriate classification is AGM Information (AGM-R).
2020-06-10 Spanish
Almirall mantendrá una teleconferencia con analistas e inversores
Report Publication Announcement Classification · 98% confidence The document is very short (872 characters) and explicitly announces an upcoming event: a webcast to present and comment on the results for the first quarter of 2020. It states that the event can be followed live and the recording will be available later on the website. This structure—announcing the availability of results commentary via a webcast—is characteristic of a Report Publication Announcement (RPA), as it is not the full results document itself (which would likely be an IR or ER), but rather the announcement of the presentation/discussion surrounding those results. It fits the 'MENU VS MEAL' rule by announcing the event where the results will be discussed, rather than being the detailed report.
2020-05-11 Spanish
Operaciones del contrato de liquidez durante el primer trimestre de 2020
Director's Dealing Classification · 95% confidence The document is a formal announcement dated May 6, 2020, from Almirall, S.A., reporting on transactions conducted under a pre-existing liquidity contract (market maker agreement) with Santander Investment Bolsa. It details the number of shares bought and sold, and the cash involved, specifically for the fourth quarter of the contract's validity (January 1, 2020, to March 31, 2020). This type of disclosure, detailing personal share transactions by executives or related parties (in this case, a market maker acting on behalf of the company for liquidity purposes, which falls under insider/related party activity reporting requirements in many jurisdictions), aligns best with the definition of Director's Dealing (DIRS) or a specific regulatory filing related to share transactions. Since the core content is the detailed reporting of share transactions (buys and sells) by an entity related to maintaining market liquidity, it strongly suggests insider/related party transaction reporting. Among the provided codes, 'DIRS' (Director's Dealing) is the closest fit for reporting on personal/related party share transactions, even if this specific report concerns a liquidity contract rather than a director's personal trade. If a more specific 'Liquidity Contract Report' existed, that would be ideal, but DIRS covers insider/related party transaction reporting generally. Given the context of reporting share transactions, DIRS is the most appropriate classification.
2020-05-06 Portuguese
Junta General Ordinaria de Accionistas
AGM Information Classification · 95% confidence The document is a short announcement dated March 24, 2020, from Almirall, S.A. The key content is the decision by the Board of Directors to 'desconvocar' (cancel/postpone) the Ordinary General Shareholders' Meeting (Junta General Ordinaria de Accionistas) originally scheduled for May 6, 2020, due to the Covid-19 situation. This is an announcement regarding the status of the AGM, not the AGM materials themselves, nor the voting results. Since it directly concerns the scheduling/cancellation of the Annual General Meeting, the most appropriate category is AGM Information (AGM-R), as it relates directly to the meeting logistics, even though it's a cancellation notice rather than presentation material. Given the short length and the nature of the announcement, it could also be considered a Regulatory Filing (RNS), but AGM-R is more specific to the subject matter.
2020-03-24 Spanish
Motivo de la notificación: Persona Estrechamente Vinculada
Director's Dealing Classification · 100% confidence The document is titled 'MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS' (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) in financial instruments (Acción/Share) conducted by a director or closely associated person of the issuer (ALMIRALL, S.A.). This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided schema definitions. The code for this is DIRS.
2020-03-13 Spanish
Almirall anuncia que la FDA ha aceptado la presentación de la solicitud para tirbanibulin como tratamiento de la queratosis actínica
Regulatory Filings Classification · 95% confidence The document is a formal communication titled "OTRA INFORMACIÓN RELEVANTE" (Other Relevant Information) from Almirall, S.A., addressed to the Comisión Nacional del Mercado de Valores (CNMV), citing Article 227 of the Spanish Securities Market Law. The core content announces that the US FDA has accepted the New Drug Application (NDA) for tirbanibulin. This type of announcement, concerning regulatory milestones for a drug application, does not fit neatly into standard financial reports (10-K, IR, ER) or corporate governance documents. It is a specific regulatory update regarding product development/approval status. Since it is a specific regulatory announcement that doesn't match other categories like M&A (TAR), Capital (CAP), or Director Dealing (DIRS), the most appropriate classification is the general regulatory filing category, RNS, as it is a mandatory disclosure of material information to the market regulator.
2020-03-09 Spanish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.